National Comprehensive Cancer Network

About NCCN

NCCN Academy Will Examine Big Data Trends in Cancer Care

By Jennifer P. Tredwell, MBA, Senior Director, Marketing

On Wednesday, March 11, 2015, the National Comprehsnsive Cancer Network® (NCCN®) will host its Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business in conjunction with the NCCN 20th Annual Conference: Advancing the Standard of Cancer Center™ at The Diplomat in Hollywood, Florida.

Clifford Goodman, PhD, The Lewin Group, will moderate this interactive program that will feature discussion with NCCN Guidelines Panel experts and other oncology stakeholders about today’s most pressing issues in oncology.

The day’s first session, Meet the New NCCN Member Institutions, features a panel of experts from the four most recently elected NCCN Member Institutions: Jan C. Buckner, MD, Mayo Clinic Cancer Center; Ned Groves, MPS, PMP, Mayo Clinic Cancer Center; Abe Lopman, MBA, Yale Cancer Center/Smilow Cancer Hospital; Thomas Lynch Jr, MD, Yale Cancer Center/Smilow Cancer Hospital; Barbara Parker, MD, UC San Diego Moores Cancer Center; W. Thomas Purcell, MD, MBA, University of Colorado Cancer Center; as well as Samuel M. Silver, MD, PhD, MACP, University of Michigan Cancer Comprehensive Cancer Center, and Chair, NCCN Board of Directors. The clinical and administrative leadership of the new NCCN Member Institutions will discuss strategy, care delivery, reimbursement challenges, and the future of cancer care.

The second panel discussion will explore current trends in the collection and utilization of real world data in advancing cancer care, featuring the following experts: Amy Abernethy, MD, PhD, Flatiron Health, Inc.; Linda House, RN, BSN, MSM, Cancer Support Community; Alexander Liede, MSc, PhD, Cancer for Observational Research, Amgen, Inc.; Robert S. Merkel, MBA, IBM Watson Group; and Robert Miller, MD, American Society of Clinical Oncology (ASCO). These panelists, pioneers in the application of big data in oncology, will discuss their groundbreaking projects and current trends in collection and use of these databases for the benefit of providers, manufacturers, payers, and especially patients.

The third module will be a special commemorative discussion titled, Meet the NCCN Guidelines Panel Experts: 20 Years of Guidelines Development, and will feature speakers including, but not limited to NCCN leadership who served on NCCN Guidelines panels in 1996 and continue to lead today: Al B. Benson III, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chair, NCCN Guidelines Panels for Colon and Rectal Cancers; Robert W. Carlson, MD, CEO, NCCN, and Former Chair, NCCN Guidelines Panel for Breast Cancer; David S. Ettinger, MD, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Chair NCCN Guidelines Panel for Non-Small Cell Lung Cancer (NSCLC); James L. Mohler, MD, Roswell Park Cancer Institute; Marcus Neubauer, MD, McKesson Corporation; and Margaret R. O’Donnell, MD, City of Hope Comprehensive Cancer Center, Chair, NCCN Guidelines Panel for Acute Myeloid Leukemia. This panel will provide expert insights into the consideration and decision-making processes that result in the recommendations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), including a look back over 20 years of progress and development, as well as insights regarding the development of the Value Pathways Powered by NCCN.

During NCCN Academy, pharmaceutical and biotechnology professionals are given the opportunity to view  operational issues from the provider and payer perspectives. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

For more information or to register, visit NCCN.org/Academy